The drugs industry closed the day down 0.2%. iBio Inc ( IBIO), Amylin Pharmaceuticals Inc ( AMLN), Transcept Pharmaceuticals Inc ( TSPT), and NovaBay Pharmaceuticals Inc ( NBY) were all winners today within the drugs industry with Merck & Co Inc ( MRK) being today's featured drugs winner. Merck & Co Inc rose 26 cents (0.8%) to $32.80 on light volume. Throughout the day, 13.4 million shares of Merck & Co Inc exchanged hands as compared to its average daily volume of 19 million shares.

Merck & Co., Inc. provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. Merck & Co Inc has a market cap of $101 billion and is part of the health care sector. The company has a P/E ratio of 35.3, above the average drugs industry P/E ratio of 34.9 and above the S&P 500 P/E ratio of 17.7. Shares are down 9% year to date as of the close of trading on Wednesday.

TheStreet Ratings rates Merck & Co as a buy. The company's strengths can be seen in multiple areas, such as its increase in net income, revenue growth, largely solid financial position with reasonable debt levels by most measures, growth in earnings per share and expanding profit margins. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself.

On the negative front, Telik Inc ( TELK), Poniard Pharmaceuticals Inc ( PARD), AspenBio Pharma Inc ( APPY), and AspenBio Pharma Inc ( APPYD) were all losers within the drugs industry with Teva Pharmaceutical Industries ( TEVA) being today's drugs industry Loser Spotlight stock.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the drugs industry could consider SPDR S&P Pharmaceuticals ETF ( XPH) while those bearish on the drugs industry could consider ProShares UltraShort Nasdaq Biotech ( BIS).